In line with the Facilities for Illness Management and Prevention, greater than 37 million folks within the U.S. have diabetes. That is a bit of greater than 11% of the complete inhabitants.
A diabetic’s physique does not make sufficient or any insulin in any respect. These with the illness should recurrently monitor their blood sugar. This has been historically performed with glucometers, which diabetics use to prick their fingers time and again for drops of blood. However during the last decade, know-how like steady glucose monitoring has been on the rise.
Abbott and Dexcom are the 2 most dominant gamers within the house. Each firms have seen elevated progress.
The know-how can be being marketed by a number of well being and wellness apps as many firms see advantages for individuals who haven’t got diabetes.
CNBC spoke with each Abbott and Dexcom in regards to the know-how inside steady glucose screens and the way they see it increasing.